Case Report
Published on 11 Aug 2022
Heterogeneity of resistant mechanisms in an EGFR-TKI relapsed patient with EGFR amplification and response to nimotuzumab: A case report
in Molecular and Cellular Oncology
- 1,856 views
- 1 citation
Case Report
Published on 11 Aug 2022
in Molecular and Cellular Oncology
Review
Published on 11 Aug 2022
in Molecular and Cellular Oncology
Review
Published on 10 Aug 2022
in Molecular and Cellular Oncology
Review
Published on 10 Aug 2022
in Molecular and Cellular Oncology
Original Research
Published on 10 Aug 2022
in Molecular and Cellular Oncology
Case Report
Published on 09 Aug 2022
in Molecular and Cellular Oncology
Original Research
Published on 09 Aug 2022
in Molecular and Cellular Oncology
Review
Published on 08 Aug 2022
in Molecular and Cellular Oncology
Review
Published on 08 Aug 2022
in Molecular and Cellular Oncology
Original Research
Published on 08 Aug 2022
in Molecular and Cellular Oncology
Methods
Published on 08 Aug 2022
in Molecular and Cellular Oncology
Original Research
Published on 08 Aug 2022
in Molecular and Cellular Oncology
Editorial
Published on 05 Aug 2022
in Molecular and Cellular Oncology
Review
Published on 04 Aug 2022
in Molecular and Cellular Oncology
Review
Published on 04 Aug 2022
in Molecular and Cellular Oncology
Original Research
Published on 04 Aug 2022
in Molecular and Cellular Oncology